BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28693015)

  • 1. Criticism of the Pap Smear as a Diagnostic Tool in Cervical Cancer Screening.
    Schneider V
    Acta Cytol; 2017; 61(4-5):338-344. PubMed ID: 28693015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Groundbreaking Work Which Laid the Foundation for Mass Screening in Cervical Cytology in Japan.
    Osamura RY
    Acta Cytol; 2017; 61(4-5):299-304. PubMed ID: 28693014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test.
    Printz C
    Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486
    [No Abstract]   [Full Text] [Related]  

  • 4. The Bethesda System for Reporting Cervical Cytology: A Historical Perspective.
    Nayar R; Wilbur DC
    Acta Cytol; 2017; 61(4-5):359-372. PubMed ID: 28693017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for cervical cancer using automated analysis of PAP-smears.
    Bengtsson E; Malm P
    Comput Math Methods Med; 2014; 2014():842037. PubMed ID: 24772188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study protocol for the most effective recall method in a cervical cancer screening program in Klang, Malaysia.
    Abdul Rashid RM; Dahlui M
    Asian Pac J Cancer Prev; 2013; 14(10):5867-70. PubMed ID: 24289591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women.
    Assoumou SZ; Mabika BM; Mbiguino AN; Mouallif M; Khattabi A; Ennaji MM
    BMC Womens Health; 2015 Apr; 15():37. PubMed ID: 25924940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
    Miller RA; Mody DR; Tams KC; Thrall MJ
    Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
    Açikgöz A; Ergör G
    Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status and future trends in cervical cancer screening.
    Castle P; Dowdall M
    Womens Health (Lond); 2014 Mar; 10(2):129-33. PubMed ID: 24147567
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of Abnormal Cervical Cytology in HIVNegative Women Participating in a Cervical Cancer Screening Program in Calmette Hospital, Cambodia.
    Hav M; Eav S; Heang N; Pich P; Lim D; Leang V; Korn A; Lay S; Pluot M; Kruy L
    Asian Pac J Cancer Prev; 2016; 17(7):3101-3. PubMed ID: 27509936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pap tests in the diagnosis of cervical cancer: Help or hinder?
    Philp L; Jembere N; Wang L; Gao J; Maguire B; Kupets R
    Gynecol Oncol; 2018 Jul; 150(1):61-66. PubMed ID: 29773301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pap smears. Still a reliable screening tool for cervical cancer.
    Stack PS
    Postgrad Med; 1997 Apr; 101(4):207-8, 211-4. PubMed ID: 9126213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pap smear intervals safe.
    AIDS Patient Care STDS; 2000 Dec; 14(12):675. PubMed ID: 11119436
    [No Abstract]   [Full Text] [Related]  

  • 15. Cervical cancer in developing countries: effective screening and preventive strategies with an application in Rwanda.
    Mukakalisa I; Bindler R; Allen C; Dotson J
    Health Care Women Int; 2014; 35(7-9):1065-80. PubMed ID: 24750113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. False-Negative Rate of Papanicolaou Testing: A National Survey from the Thai Society of Cytology.
    Koonmee S; Bychkov A; Shuangshoti S; Bhummichitra K; Himakhun W; Karalak A; Rangdaeng S
    Acta Cytol; 2017; 61(6):434-440. PubMed ID: 28738387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.
    Eltabbakh GH; Eltabbakh GD
    J Womens Health Gend Based Med; 1999 May; 8(4):469-76. PubMed ID: 10839701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer screening in Korea: report on the National Cancer Screening Programme in 2008.
    Mun JY; Han MA; Lee HY; Jun JK; Choi KS; Park EC
    Asian Pac J Cancer Prev; 2011; 12(8):1961-4. PubMed ID: 22292633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical screening in Western Kazakhstan: Liquid-based cytology 'Cell Scan' versus azur-eosin staining.
    Balmagambetova S; Gabutti G; Koyshybaev A; Acuti Martellucci C; Urazayev O; Sakiyeva K; Bekova K
    J Med Screen; 2020 Jun; 27(2):90-95. PubMed ID: 31744375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
    Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
    J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.